221 related articles for article (PubMed ID: 19185908)
1. Combined androgen blockade revisited: emerging options for the treatment of castration-resistant prostate cancer.
Simmons MN; Klein EA
Urology; 2009 Apr; 73(4):697-705. PubMed ID: 19185908
[No Abstract] [Full Text] [Related]
2. A re-assessment of the role of combined androgen blockade for advanced prostate cancer.
Klotz L; Schellhammer P; Carroll K
BJU Int; 2004 Jun; 93(9):1177-82. PubMed ID: 15180600
[No Abstract] [Full Text] [Related]
3. Chemotherapy in patients with castration-resistant prostate cancer.
Meulenbeld HJ; Hamberg P; de Wit R
Eur J Cancer; 2009 Sep; 45 Suppl 1():161-71. PubMed ID: 19775615
[No Abstract] [Full Text] [Related]
4. Combined castration and androgen blockade therapy in prostate cancer. Conclusions.
Denis L; Mettlin C
Cancer; 1990 Sep; 66(5 Suppl):1086-9. PubMed ID: 2203520
[No Abstract] [Full Text] [Related]
5. Antiandrogens in the treatment of prostate cancer.
Wirth MP; Hakenberg OW; Froehner M
Eur Urol; 2007 Feb; 51(2):306-13; discussion 314. PubMed ID: 17007995
[TBL] [Abstract][Full Text] [Related]
6. [Cancer of the prostate. What treatment, for which patient, in 1986?].
Boccon-Gibod L
Ann Urol (Paris); 1986; 20(2):79-81. PubMed ID: 3717903
[No Abstract] [Full Text] [Related]
7. [Maximal androgen blockade in metastatic prostatic carcinoma].
Jørgensen T; Tveter KJ
Tidsskr Nor Laegeforen; 1997 Jan; 117(3):381-3. PubMed ID: 9064862
[TBL] [Abstract][Full Text] [Related]
8. Effects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade.
Woodward WA; Wachsberger P; Burd R; Dicker AP
Prostate Cancer Prostatic Dis; 2005; 8(2):127-32. PubMed ID: 15643450
[TBL] [Abstract][Full Text] [Related]
9. [Endocrine therapy versus observation after R0 resection in node positive prostate cancer].
Kleeberg UR
Strahlenther Onkol; 2000 Jun; 176(6):293-4. PubMed ID: 10897259
[No Abstract] [Full Text] [Related]
10. Novel concepts in androgen receptor blockade.
Hsieh AC; Ryan CJ
Cancer J; 2008; 14(1):11-4. PubMed ID: 18303477
[TBL] [Abstract][Full Text] [Related]
11. Castration-resistant prostate cancer--hormone therapy redux.
Tolcher AW; Cooper J
J Clin Oncol; 2010 Mar; 28(9):1447-9. PubMed ID: 20159817
[No Abstract] [Full Text] [Related]
12. Metastatic prostate cancer presenting as paraneoplastic pemphigus: a favourable clinical response to combined androgen blockade and conventional immunosuppressive therapy.
Mignogna MD; Fortuna G; Leuci S; Adamo D; Ruoppo E
Br J Dermatol; 2009 Feb; 160(2):468-70. PubMed ID: 19120335
[No Abstract] [Full Text] [Related]
13. [Clinical usefulness of chlormadinone acetate as an alternative antiandrogen therapy for prostate cancer relapse after combined androgen blockade therapy].
Ehara H; Katoh S; Nakane K; Katoh T; Takada T; Kojima K; Kamei S; Hagiwara N; Yuhara K; Takahashi Y; Fujimoto Y; Fujihiro S; Kanimoto Y; Deguchi T
Hinyokika Kiyo; 2009 Apr; 55(4):199-203. PubMed ID: 19462824
[TBL] [Abstract][Full Text] [Related]
14. A combination treatment for localized prostate cancer.
Mayo Clin Health Lett; 2005 Feb; 23(2):4. PubMed ID: 15732168
[No Abstract] [Full Text] [Related]
15. Novel secondary hormonal therapy in advanced prostate cancer: an update.
Van Allen EM; Ryan CJ
Curr Opin Urol; 2009 May; 19(3):315-21. PubMed ID: 19342958
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer (non-metastatic).
Wilt T
Clin Evid; 2003 Dec; (10):1023-38. PubMed ID: 15555136
[No Abstract] [Full Text] [Related]
17. Prostate cancer (non-metastatic).
Wilt T
Clin Evid; 2003 Jun; (9):973-85. PubMed ID: 12967402
[No Abstract] [Full Text] [Related]
18. Where is radiotherapy for stage C prostate cancer headed?
Hanks GE
Contemp Urol; 1994 Mar; 6(3):11-4. PubMed ID: 10146746
[No Abstract] [Full Text] [Related]
19. Trial design for metastatic castration-resistant prostate cancer.
Sonpavde G; Fleming MT; Hutson TE; Galsky MD
J Clin Oncol; 2008 Jul; 26(21):3647-8; author reply 3648-9. PubMed ID: 18640946
[No Abstract] [Full Text] [Related]
20. Emerging drugs for prostate cancer.
Siddiqui K; Klotz LH
Expert Opin Emerg Drugs; 2009 Sep; 14(3):455-70. PubMed ID: 19650748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
